Takeda Head Admits Firm Behind In Replacing Patent-Losing Blockbusters
This article was originally published in PharmAsia News
Executive Summary
CEO says the near future for overcoming patent losses of key drugs is not rosy, due in part to a gap between expirations and getting well-selling substitutes to market.